Continuous Positive Airway Pressure (CPAP) Market Overview
An alarming rise in the number of chronic obstructive pulmonary disorder (COPD) and a rapid visible increase in the diagnosis rate of sleep apnea/hypopnea syndrome (SAHS), are further complemented by the expanding geriatric population. The demand for lung pulmonary airway disease treatment is also on the rise. While these factors collectively contribute towards the demand for respiratory assistance therapy and devices, particularly continuous positive airway pressure (CPAP), the recently declared global COVID-19 pandemic is observed to be a solid booster to the global CPAP market landscape.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11187
Moreover, technological advances such as improved mask designs continue to account for accelerating demand for CPAP devices. Design innovations are primarily driven by lack of 100% comfort wearing these masks, as reported by patients over the years.
Stretching Beyond Traditional Application Areas
Continuous positive airway pressure machines are typically utilized as assistive/supportive and preventive devices to treat patients of SAHS, acute asthma, cardiogenic pulmonary edema, congestive heart failure, chronic lung disease (CLD), cystic fibrosis, and in COPD treatment. Of late, they are finding application in providing breathing assistance, rather, as a potential substitute for ventilator.
After the FDA’s recent emergency policy, various alternative respiratory devices emerged to be used as potential replacers for lifesaving ventilators. In light of shortages of ventilators that quickly began to influence the scenario at hospitals and emergency response centers during the novel coronavirus pandemic, CPAP devices started witnessing greater preference among others in the category. However, as suggested by the American Society of Anesthesiologists’ guidance, utilization of such non-invasive respiratory devices must be subject to additional caution as it is often prone to dispersal of unfiltered droplets, eventually adding to the air-borne infection of virus.
For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-11187
Although the increasingly significant role of CPAP in providing rapid and cost-competitive treatment to COVID-19 patients is placing it much beyond its traditional areas of application, it becomes imperative to comprehend its actual scope of application and viability in these times. Looking at the existing shortcomings of CPAP in effectively compensating for the undersupply of ventilators, it is of paramount importance to keep abreast of the latest innovations entering the CPAP space.
CPAP Devices – Ventilator Replacement in COVID-19 Outbreak?
With industry behemoths such as GE Healthcare and Medtronic ramping up their ventilator production, the latter expects over 40% rise in its global production levels in the near future. The former, on the other side, announced the plan of establishment of its multiple manufacturing facilities in the following years. ResMed also recently revealed its significant production capacity expansion, in collaboration with Tesla, during the past three months.
Future Market Insights (FMI), in this pipeline report, provides a deep-dive analysis of the global CPAP market. In addition to offering a detailed assessment of the key market dynamics and the forthcoming opportunities facing potential investors, the report predominantly covers the impact of novel coronavirus outbreak on the various CPAP market elements over the course of near future.
Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-11187
CPAP machines are being effectively used in treating COVID-19 patients with less severe issues with breathing. However, experts opine that these CPAP machines are themselves capable of aiding the spread of infection irrespective of at hospitals or home care settings. Aerosolization of the coronavirus due to CPAP masks remains a major concern, which adds to the scepticism regarding adoption of CPAP as a substitute for ventilator. Research shows that face masks that are used for CPAP or bilevel PAP (BiPAP) tend to let air escape, along with the virus, eventually infecting others in the vicinity, including healthcare providers, and patients.
Embracing Innovations to Brave the Challenges
The most commonly observed side effects of CPAP include the claustrophobic feeling under masks, runny nose, nasal congestion, and a greater risk of contamination due to aerosol generation. These factors prevail as key challenges to wider recommendation of CPAP devices. Moreover, the paucity of patient compliance during diagnosis and treatment will remain a hindrance to broader adoption of CPAP units. Expensive price point of respiratory assistance devices, CPAP therapy administration and associated products also stands as an impediment to skyrocketing demand.
However, the market is recently witnessing an influx of novel innovations that decently attempt to present competitively priced products with a better comfort quotient. Rapid turnaround and mass production compatibility are currently the top parameters on the minds of these innovators to cater to respiratory assistance needs of COVID-19 patients at the earliest.
Global CPAP Market Segmentation
- Based on the type of product, the CPAP market can be segmented into CPAP devices and CPAP accessories.
- On the basis of operation, the market can be classified as manual and automatic.
- According to the type of patients, the market can be categorized as paediatric and adult.
- Based on their end-use area, the study on CPAC market classifies the market into three sub-segments, viz. hospitals, home care settings, and private clinics.
- The detailed market taxonomy is studied for seven key regional markets, including North America, Latin America, Western Europe, Eastern Europe, China, Asia Pacific excluding China, and Middle East & Africa.
CPAP Market Structure Analysis
This FMI study, in addition to providing some solid actionable insights on the increasingly significant role of CPAP machines in combating the coronavirus crisis, offers information on the latest developments of market leaders in this regard.
Some of the prominent companies active in the global CPAP market landscape that are profiled in the report include ResMed, Koninklijke Philips, Medtronic, Armstrong Medical Inc., Smiths Medical, Cardinal Health, Apex Medical Corp., Koike Medical, DeVilbiss Healthcare LLC, Beijing Dehaier Medical Technology, Teijin Pharma, BMC Medical, Fosun Pharma, 3B Medical, Inc., Fisher & Phillips LLP, and Invacare Corporation.
The global market landscape continues to reflect a fragmented nature, yet continues to witness primacy of leading international players. Product features, competitive pricing structure, and reliability act as the key differentiating touchpoints for companies competing in the market.
Recently, a British Formula 1 engine manufacturer – Mercedes-AMG High Performance Powertrains (Northamptonshire), developed an efficient breathing aid in form of a CPAP unit to respond to the expected rise in COVID-19 patients with breathing difficulties. This device has been developed through reverse engineering one of their existing devices, and it definitely eliminates the need for a ventilator.